Magnus Nilsson

Chairman chez MENTICE AB Fortune : 32 639 $ au 31/03/2024

Profil

Magnus Nilsson is the founder of Xvivo Perfusion AB, which was founded in 1998.
He held the title of CEO, Director & Media Relations Person from 2012 to 2014.
Dr. Nilsson's current job is President & Chief Executive Officer at Sandahlsbolagen Sweden AB.
He is also the Chairman at Mentice AB since 2022, an Independent Director at Cantargia AB since 2021, a Director at Corline Biomedical AB since 2020, and a Director at Magnus Hl Nilsson Management Consulting AB.
Dr. Nilsson's former jobs include being the President & Chief Executive Officer at Vitrolife AB from 1998 to 2011.
He was also the Chairman at XVIVO Perfusion Lund AB and IFK Göteborg Fotboll AB.
Dr. Nilsson served as a Director at Dignitana AB, Dipylon Medical AB, SwedenBIO Service AB, and Aptic AB.
From 2014 to 2019, he was a Director at Mendus AB.
Dr. Nilsson also held positions as a Director at Vitrolife Sweden Instruments Holding AB and Deputy Director at Svenska Jutekompaniet AB.
He worked as a Project Manager-Drug Development Projects at Karobio AB and Pharmacia & Upjohn AB.
Dr. Nilsson obtained a doctorate degree from the University of Uppsala.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
CANTARGIA AB 0,05%	31/12/2022	100 000 ( 0,05% )	32 639 $	31/03/2024

Postes actifs de Magnus Nilsson

Sociétés	Poste	Début
CORLINE BIOMEDICAL AB	Director/Board Member	-
MENTICE AB	Chairman	30/12/2022
CANTARGIA AB	Director/Board Member	26/05/2021
Sandahlsbolagen Sweden AB	Chief Executive Officer	-
Magnus Hl Nilsson Management Consulting AB	Director/Board Member	-

Anciens postes connus de Magnus Nilsson

Sociétés	Poste	Fin
XVIVO PERFUSION AB	Founder	01/06/2020
MENDUS AB	Director/Board Member	25/04/2019
VITROLIFE AB	Chief Executive Officer	31/10/2011
DIGNITANA AB	Director/Board Member	-
░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-

Formation de Magnus Nilsson

University of Uppsala

Doctorate Degree